Copper Peptides: GHK-Cu, AHK-Cu, and What They Actually Do

Copper peptides are short amino-acid sequences bound to a copper ion. The two most-studied are GHK-Cu (glycyl-histidyl-lysine + copper) and AHK-Cu (alanyl-histidyl-lysine + copper). Decades of topical-cosmetic data support modest but real effects on skin regeneration, collagen synthesis, and hair-follicle stimulation. Injected use is much less studied and is generally a research-only practice. This guide covers the mechanism, evidence by route of administration, dosing, side effects, and how to evaluate a serum.

For the per-peptide research profile, see GHK-Cu and AHK-Cu.

The mechanism

Copper peptides bind copper(II) and deliver it to tissues where it acts as a cofactor for two key enzymes:

1. Lysyl oxidase — cross-links collagen and elastin fibers, which is required for dermal structural integrity.
2. Superoxide dismutase (Cu/Zn-SOD) — neutralizes reactive oxygen species, modulating oxidative damage.

GHK-Cu specifically has additional bioactivity attributed to the GHK tripeptide itself (independent of the copper): direct modulation of wound-healing gene expression, fibroblast proliferation, and modest anti-inflammatory effect.

AHK-Cu is structurally similar to GHK-Cu but with alanine in the first position. The mechanism story is similar; the strongest published use case is dermal-papilla stimulation for hair growth.

What the evidence shows by route

Topical GHK-Cu — strongest evidence base

Used in cosmetic chemistry since the 1990s. Published evidence supports:

• Reduced fine lines and improved skin texture at concentrations of 1–3% in serum formulations across 12 weeks.
• Improved skin elasticity measured by cutometer.
• Accelerated wound healing in topical post-procedure protocols.
• Reduced pigmentation in some studies (modest effect).

Effect size is modest — comparable to a good retinoid or vitamin C serum, not a transformation. Combination products (retinoid + peptide + antioxidant) usually outperform any single ingredient.

Topical AHK-Cu — narrower but real

Most-cited use case: hair-follicle stimulation. Some published evidence supports:

• Increased hair density in androgenetic-alopecia models with topical application.
• Increased follicle size in dermal-papilla cell-culture studies.

Used in some hair-growth serums alongside minoxidil and finasteride. Effect is supportive, not standalone.

Injected GHK-Cu — limited human data

Some research-use practices inject GHK-Cu subcutaneously for systemic skin-regeneration and tendon-healing endpoints. Evidence base is weaker than topical use. The mechanism story is plausible (copper-peptide signaling); the human-trial data is largely absent.

Typical research dosing: 1–2 mg per dose, 2–3× weekly, in 4–8 week cycles.

For injection technique, see how to inject peptides and where to inject peptides. For dose math, see the calculator.

Injected AHK-Cu — minimal human data

Even less well-studied than injected GHK-Cu. Use is largely speculative outside research settings.

Topical formulation considerations

If buying a copper peptide serum:

• Concentration matters. Look for 1–3% GHK-Cu specifically called out, not just "contains copper peptides."
• pH compatibility. Copper peptides are stable in acidic-to-neutral pH (4–7). Highly alkaline formulations destabilize them.
• Vitamin C interaction. L-ascorbic acid (vitamin C) can chelate copper and inactivate the peptide if applied simultaneously. Alternate AM/PM if both are in your routine.
• Retinoid interaction. Generally compatible. Use peptide AM, retinoid PM, or alternate days.
• Sun protection. Copper peptides don't increase sun sensitivity, but the active-skincare stack as a whole is more effective with daily SPF.
• Packaging. Air- and light-exposure degrade copper peptides. Pump bottles or airless dispensers > jars.

Side effects

Topical:

• Mild local irritation in a small fraction of users (1–5%). Patch test before full application.
• Transient skin discoloration (greenish-blue tint at application) is the natural color of the complex and washes off. Some users prefer formulations without visible color.

Injected:

• Standard injection-site reactions.
• No serious systemic side effects reported in the limited published data, but the chronic-use safety profile is unstudied.

How copper peptides compare with other cosmetic-active peptides

Peptide	Primary effect	Evidence base	Form
GHK-Cu	Collagen synthesis, regeneration	Decades topical, limited injected	Both
AHK-Cu	Hair growth, dermal papilla	Topical only realistically	Topical
Argireline (Acetyl Hexapeptide-8)	Wrinkle reduction (muscle-relaxing)	Strong topical	Topical
Matrixyl (Palmitoyl Pentapeptide-4)	Collagen synthesis	Strong topical	Topical
SNAP-8 (Acetyl Octapeptide-3)	Wrinkle reduction	Topical	Topical
Melanotan I/II	Pigmentation	Injected	Injected

See peptides for skin for the broader cosmetic-peptide landscape.

Practical recommendations

• Buy reputable brands with disclosed concentrations and stability-tested formulations. The cosmetic-peptide market has been around long enough that quality is identifiable.
• Apply to clean skin in the AM after cleansing, before sunscreen. PM is fine too if AM has too many actives.
• Give it 8–12 weeks to evaluate. Topical actives are slow; weekly judgments are noise.
• Combination beats single-ingredient. A morning routine with peptide serum + antioxidant + SPF outperforms any monotherapy.
• For injected use: This is a research-use practice. Evidence is limited. If pursuing it, work with a clinician familiar with research peptides, run baseline / follow-up labs, and rotate sites.

Where to go from here

• Per-peptide research profile: GHK-Cu, AHK-Cu.
• Cosmetic / skin context: peptides for skin, skin hub.
• Hair-growth context: hair-growth hub.
• Operational guides (if going injected): how to reconstitute peptides, how to inject peptides, calculator.
• Safety: are peptides safe?.